Antiarrhythmic and hemodynamic effects of calcium channel blocking agents during coronary arterial reperfusion. Comparative effects of verapamil and nifedipine.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001145:Arrhythmias, Cardiac / Q000209:etiology; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D003326:Coronary Circulation / Q000187:drug effects; D003331:Coronary Vessels; D004285:Dogs; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D007473:Ion Channels / Q000187:drug effects*; D008297:Male; D009543:Nifedipine / Q000494:pharmacology; D010477:Perfusion; D014700:Verapamil / Q000494:pharmacology
D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers; D007473:Ion Channels; D014700:Verapamil; D009543:Nifedipine